Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - KING PHARMACEUTICALS INC | g21874e10vk.htm |
| EX-31.2 - EX-31.2 - KING PHARMACEUTICALS INC | g21874exv31w2.htm |
| EX-32.1 - EX-32.1 - KING PHARMACEUTICALS INC | g21874exv32w1.htm |
| EX-23.1 - EX-23.1 - KING PHARMACEUTICALS INC | g21874exv23w1.htm |
| EX-31.1 - EX-31.1 - KING PHARMACEUTICALS INC | g21874exv31w1.htm |
| EX-21.1 - EX-21.1 - KING PHARMACEUTICALS INC | g21874exv21w1.htm |
| EX-10.65 - EX-10.65 - KING PHARMACEUTICALS INC | g21874exv10w65.htm |
| EX-10.64 - EX-10.64 - KING PHARMACEUTICALS INC | g21874exv10w64.htm |
EXHIBIT 32.2
CERTIFICATION
OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this annual report on
Form 10-K
of King Pharmaceuticals, Inc. I, Joseph Squicciarino, Chief
Financial Officer of King Pharmaceuticals, Inc., certify,
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:
1. The report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of
1934; and
2. The information contained in this report fairly
presents, in all material respects, the financial condition and
results of operations of King Pharmaceuticals, Inc.
/s/ Joseph
Squicciarino
Joseph Squicciarino
Chief Financial Officer
Date: February 25, 2010